Skip to evidence report

GRNLSA.p53_damage: Studies — page 11

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 297 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 10,001–11,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for GRNLSA.p53_damage
#Trait / studyIndividual trait IDMean IC score
10001AHSP/CA2 ratioGCST903132151.72e-03
10002Anxiety disorders (more control exclusions)FING000000981.72e-03
10003Treatment speciality of consultant (recoded) - Urology | Summary AdministrationUKBB000008381.72e-03
10004Clinical anxiety and depression (confirmatory factor analysis Factor 3)GCST903093381.71e-03
10005Lysoalkylphosphatidylcholine (O-20:0) levelsGCST900241931.70e-03
10006Papulosquamous disordersFING000011441.70e-03
10007Impacted cerumen (PheCode 380.4)GCST904759011.69e-03
10008Disorders of choroid and retinaFING000004381.68e-03
10009Cervical disc disordersFING000002651.67e-03
10010PDLIM7 levelsGCST904701981.67e-03
10011Hyphaema and other vascular disorders of iris and ciliary bodyFING000006471.67e-03
10012Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T23ECGU0000231.67e-03
10013rfMRI connectivity (ICA100 edge 605)GCST900054581.67e-03
10014RNASE1 levelsGCST904704761.67e-03
10015Left ventricular end diastole inferior wall thicknessGCST902785151.67e-03
10016ITGB1BP2/LAT2 ratioGCST903152121.66e-03
10017ChalazionFING000002671.66e-03
10018Working memoryGCST905031161.66e-03
10019FAS levelsGCST900907011.66e-03
10020Left-hemisphere visual network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026581.65e-03
10021COL2A1 levelsGCST904688161.64e-03
10022IDP T1 FAST ROIs R cerebellum XGCST900025891.64e-03
10023Physical activity (Total log acceleration 12am-2am)GCST900614091.63e-03
10024Free androgen indexGCST902398241.62e-03
10025Plasma X-25279 levels in chronic kidney diseaseGCST902668351.62e-03
10026TGFBI levelsGCST904708451.62e-03
10027LAT/SPARC ratioGCST903152881.62e-03
10028Volume of left whole amygdalaGCST904749881.61e-03
10029aparc-Desikan rh area lingualGCST900031191.61e-03
10030Systolic blood pressureGCST900187521.61e-03
10031wg rh intensity-contrast lingualGCST900038391.61e-03
10032Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T426ECGA0004261.60e-03
10033Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING000012031.60e-03
10034VTI1A levelsGCST904710601.59e-03
10035DTI TBSS L2 Sagittal stratum LGCST903845071.59e-03
10036T1 FreeSurfer pial rh pericalcarine areaGCST903858421.59e-03
10037AmygNuclei lh volume Cortical-nucleusGCST900026541.59e-03
10038NFE2 levelsGCST904700351.58e-03
10039Weight (mean, inv-normal transformed)GCST904764631.58e-03
10040Free testosterone levelsGCST902398261.58e-03
10041Takes medication for Glaucoma?GCST904753841.57e-03
10042Mean platelet volume at deliveryGCST903022321.57e-03
10043Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004281.57e-03
10044Creatinine levels (UKB data field 23478)GCST902695751.57e-03
10045Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T425ECGA0004251.57e-03
10046Frequency of travelling from home to job workplace | EmploymentUKBB000002691.56e-03
10047RNF43 levelsGCST904704861.56e-03
10048BACH1/NFATC1 ratioGCST903134441.56e-03
10049Other and unspecified polyneuropathies, also in other diseasesFING000009481.56e-03
10050Fractured bone site(s) - Other bones | Medical conditionsUKBB000002561.56e-03
10051Internal derangement of knee (PheCode 835)GCST904762821.56e-03
10052DTI TBSS L1 Superior longitudinal fasciculus LGCST903844691.56e-03
10053PHYKPL levelsGCST904702281.56e-03
10054Peptic ulcer (excl. esophageal) | digestiveUKBB000006391.56e-03
10055CDHR2/MME ratioGCST903139631.56e-03
10056SEPTIN8 levelsGCST904705781.56e-03
10057LCN2/S100A12 ratioGCST903153091.55e-03
10058Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T433ECGU0004331.55e-03
10059Illnesses of mother - High blood pressure | Family historyUKBB000003481.55e-03
10060Breast cancer | neoplasmsUKBB000001091.55e-03
10061B2M levelsGCST904684091.55e-03
10062LSIL lesion of the cervix uteriFING000007321.55e-03
10063aparc-DKTatlas rh area parstriangularisGCST900032831.54e-03
10064Ulcerative rectosigmoiditisFING000013941.54e-03
10065SHBG levelsGCST905033151.54e-03
10066aparc-a2009s rh volume S-orbital-H-ShapedGCST900030621.54e-03
10067TPK1 levelsGCST904709431.53e-03
10068ThalamNuclei lh volume MDlGCST900027241.53e-03
10069Osteopathies and chondropathiesFING000009131.52e-03
10070T1 FreeSurfer DK lh precentral thicknessGCST903856451.52e-03
10071Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T30ECGU0000301.52e-03
10072CREG1/GUSB ratioGCST903142491.51e-03
10073Left-hemisphere control network to right-hemisphere visual network white-matter structural connectivityGCST903027451.50e-03
10074EDAR/SDC4 ratioGCST903145851.49e-03
10075Illnesses of siblings - Diabetes | Family historyUKBB000003501.49e-03
10076CD2AP/USP8 ratioGCST903137841.49e-03
10077ATG4A levelsGCST904683841.49e-03
10078Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64ECGA0000641.49e-03
10079Forced expiratory volume in 1-second (FEV1), predicted percentage | SpirometryUKBB000002531.49e-03
10080AGXT levelsGCST904682581.49e-03
10081Volume of right whole amygdalaGCST904750541.48e-03
10082PCBD1 levelsGCST904701661.48e-03
10083Intestinal infectious diseasesFING000006891.47e-03
10084Blood cell traits latent factor 7 (white cell)GCST905592491.47e-03
10085Edema (PheCode 782.3)GCST904762721.46e-03
10086BMP6/SPINT2 ratioGCST903135291.46e-03
10087Pelvic inlet widthGCST904489101.46e-03
10088ANGPT1/PDGFA ratioGCST903132661.46e-03
10089Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460ECGA0004601.46e-03
10090Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T17ECGU0000171.45e-03
10091IDP dMRI TBSS MO Cerebral peduncle RGCST900039661.45e-03
10092Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T266ECGU0002661.45e-03
10093LTBR levelsGCST902431761.45e-03
10094DNMBP/WWP2 ratioGCST903145221.45e-03
10095CXCL17/SFTPA2 ratioGCST903143411.45e-03
10096T1 FreeSurfer aseg Right-Lateral-VentricleGCST903841571.44e-03
10097TNFRSF1A levelsGCST900120151.44e-03
10098Retention of urineFING000012571.44e-03
10099Treatment/medication code - perindopril | MedicationsUKBB000008541.43e-03
10100Nontoxic multinodular goiter | endocrine/metabolicUKBB000005281.43e-03
10101TSTA3 levelsGCST904218541.43e-03
10102FYB1/PPP1R12A ratioGCST903149131.43e-03
10103Migraine with auraFING000008191.43e-03
10104Asthma, unspecified (mode)FING000001201.43e-03
10105DECR1/FXN ratioGCST903144461.43e-03
10106Male-pattern baldnessGCST0066611.43e-03
10107MMP9/PLAUR ratioGCST903154701.42e-03
10108Gestational [pregnancy-induced] oedema and proteinuria without hypertensionFING000005721.42e-03
10109Total cerebellar volume (excluding Crus I vermis)GCST900201901.42e-03
10110IL15/NCR1 ratioGCST903151501.42e-03
10111Hemorrhagic fever with renal syndromeGCST904541901.42e-03
10112SLMAP levelsGCST904706731.42e-03
10113Malignant neoplasm of breast | Malignant neoplasm of breastUKBB000004241.42e-03
10114Nephritis and nephropathy in diseases classified elsewhere (PheCode 580.31)GCST904761161.41e-03
10115Volume of right accessory basal nucleusGCST904749071.41e-03
10116Macular degeneration (senile) of retina NOS (PheCode 362.29)GCST904758571.41e-03
10117AHCY levelsGCST904682591.41e-03
10118FABP1/SULT2A1 ratioGCST903147551.41e-03
10119Blood cell traits latent factor 6 (red cell (and basophil))GCST905592481.41e-03
10120Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3ECGU0000031.41e-03
10121total creatine kinase (minimum, inv-norm transformed)GCST904764161.40e-03
10122Chronic bronchitisGCST900186041.40e-03
10123Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST902648321.40e-03
10124IDP dMRI TBSS FA Cingulum cingulate gyrus RGCST900039111.40e-03
10125Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T454ECGA0004541.40e-03
10126MANF/TXNDC5 ratioGCST903153701.40e-03
10127Single spontaneous deliveryFING000013071.40e-03
10128T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109)GCST903209281.40e-03
10129CD20 on IgD- CD38- B cellGCST900017551.39e-03
10130GOLGA3 levelsGCST904693751.39e-03
10131Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T452ECGA0004521.39e-03
10132Isolated hypothyroxinemia in pregnancyGCST904351981.39e-03
10133ESM1 levelsGCST900120681.38e-03
10134Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T445ECGA0004451.38e-03
10135DorsalgiaFING000004721.38e-03
10136CD84/TREML2 ratioGCST903139191.38e-03
10137Clonal hematopoiesis (large clone)GCST901026211.38e-03
10138CNTN4 levelsGCST902407861.38e-03
10139Birth size (multivariate analysis)GCST906241011.38e-03
10140CKMB levelsGCST904752211.37e-03
10141Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T271ECGU0002711.37e-03
10142wg lh intensity-contrast paracentralGCST900038081.37e-03
10143Hypo-osmolality and hyponatraemiaFING000006481.37e-03
10144TNFAIP2 levelsGCST904708961.36e-03
10145IDP dMRI ProbtrackX L1 ptr lGCST900042651.35e-03
10146IDP dMRI TBSS ICVF Fornix cres+Stria terminalis RGCST900043651.35e-03
10147DUSP29 levelsGCST904690521.35e-03
10148KIR2DL3 levelsGCST904696851.35e-03
10149Anterior diffusion tensor imaging along the perivascular space indexGCST904555431.35e-03
10150SMTN levelsGCST904706891.35e-03
10151Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7ECGU0000071.34e-03
10152Waist-to-hip ratio adjusted for BMIGCST0122301.34e-03
10153SLC5A8 levelsGCST902428501.34e-03
10154SWAP70 levelsGCST902429311.34e-03
10155Reimbursement for rheumatic diseasesFING000012471.34e-03
10156Right-hemisphere somatomotor network to hippocampus white-matter structural connectivityGCST903027981.32e-03
10157Vitamin and mineral supplements - Multivitamins +/- minerals | MedicationUKBB000009001.32e-03
10158Prospective memory result | Prospective memoryUKBB000007131.32e-03
10159UGDH levelsGCST904710061.32e-03
10160Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T483ECGA0004831.32e-03
10161BA-exvivo lh area V1GCST900032161.32e-03
10162Myocardial fractal dimension (slice 5)GCST900002911.32e-03
10163FUT8/TNFSF14 ratioGCST903148951.31e-03
10164Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T427ECGA0004271.31e-03
10165DTI autoptx L2 str r tractGCST903851901.31e-03
10166KRT19 levelsGCST904697171.31e-03
10167TCN1 levelsGCST904708191.31e-03
10168MMP3 levelsGCST900120271.31e-03
10169Episodal and paroxysmal disordersFING000005141.30e-03
10170GlaucomaFING000005771.30e-03
10171IGFBP6/SMOC2 ratioGCST903151381.30e-03
10172Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T424ECGA0004241.29e-03
10173Barrett's esophagus or Esophageal adenocarcinomaGCST0037401.29e-03
10174PYDC1 levelsGCST904703971.29e-03
10175Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T55ECGU0000551.28e-03
10176IDP dMRI ProbtrackX L2 cgc rGCST900042781.28e-03
10177IDP dMRI TBSS MD Retrolenticular part of internal capsule RGCST900040471.28e-03
10178Psoas tendinitisFING000012211.28e-03
10179Chronic sinusitis (PheCode 475)GCST904760201.28e-03
10180Campesterol levelsGCST901997251.28e-03
10181Medication use (immunosuppressants)GCST900187711.28e-03
10182Malignant neoplasm, excluding all cancers (controls excluding all cancers)FING000007801.28e-03
10183Eosinophil percentage of white cellsGCST900023821.28e-03
10184Usual side of head for mobile phone use - Right | Electronic device useUKBB000008901.27e-03
10185Vanillylmandelate (VMA) levelsGCST902003091.27e-03
10186aparc-a2009s rh area G-occipital-supGCST900033901.27e-03
10187T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91)GCST903206541.27e-03
10188DBNL/HSPA1A ratioGCST903144181.27e-03
10189Principal component-derived dietary pattern 36GCST901330411.27e-03
10190Smoking/smokers in household | SmokingUKBB000007831.27e-03
10191Never eat eggs, dairy, wheat, sugar - I eat all of the above | DietUKBB000005001.27e-03
10192Asthma with exacerbation (PheCode 495.2)GCST904760251.26e-03
10193Ovarian cystFING000011321.26e-03
10194N-acetyl-2-aminoadipate levelsGCST902002681.26e-03
10195Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T496ECGU0004961.26e-03
10196CLEC1B/EGF ratioGCST903140891.26e-03
10197Atrophic disorders of skinFING000001291.26e-03
10198FCER2 levelsGCST904691991.26e-03
10199Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T49ECGU0000491.25e-03
10200DSC2/EFEMP1 ratioGCST903145551.25e-03
10201Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T69ECGA0000691.25e-03
10202wg rh intensity-contrast inferiorparietalGCST900038341.25e-03
10203SYAP1 levelsGCST904707921.24e-03
10204Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T117ECGU0001171.24e-03
10205Bariatric surgery (PheCode 539)GCST904760551.24e-03
10206Volume of right lateral nucleusGCST904750391.23e-03
10207Cereal intake | DietUKBB000001211.23e-03
10208HTRA2/TRIAP1 ratioGCST903150991.23e-03
10209Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T21ECGU0000211.23e-03
10210IDP T1 FAST ROIs L cerebellum VIIIbGCST900025811.23e-03
10211Non-ischemic cardiomyopathyFING000008731.22e-03
10212SERPINE1/USP8 ratioGCST903158351.22e-03
10213T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 108)GCST903206711.22e-03
10214Pain type(s) experienced in last month - None of the above | PainUKBB000006311.21e-03
10215T1 CAT volume Vermis VIIIaGCST903841281.21e-03
10216Insomnia complaintsGCST0064871.21e-03
10217RNASE6 levelsGCST904704791.21e-03
10218REST UKBBICA NODEamps25 0016GCST903854991.20e-03
10219Hypertensive heart disease (PheCode 401.21)GCST904759251.20e-03
10220Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T39ECGU0000391.20e-03
10221wg rh intensity-contrast cuneusGCST900038311.20e-03
10222Mean volume of bilateral amygdalaGCST904749941.19e-03
10223CD48/SLAMF7 ratioGCST903138421.19e-03
10224Fasting glucoseGCST902786281.19e-03
10225IL12B levelsGCST904695491.19e-03
10226Other infective otitis externaFING000010601.18e-03
10227DTI TBSS MO Middle cerebellar peduncleGCST903846201.18e-03
10228Rheumatoid arthritisGCST900186901.18e-03
10229Waist-hip ratioGCST902786491.18e-03
10230Autorefraction - 3mm strong meridian angle (left) | EyesightUKBB000000671.17e-03
10231CLEC1B/DKK1 ratioGCST903140881.17e-03
10232IDP T1 FIRST right caudate volumeGCST900024391.17e-03
10233DTI TBSS L1 Body of corpus callosumGCST903844311.17e-03
10234Diastolic blood pressure (UKB data field 4079)GCST904681631.17e-03
10235MenorrhagiaFING000008081.17e-03
10236Bone density Z-scoreGCST902786211.15e-03
10237TNFRSF13C/TNFSF13B ratioGCST903159341.15e-03
10238TIA1/USP8 ratioGCST903159201.15e-03
10239Rheumatoid arthritisGCST901322231.15e-03
10240Benign neoplasm: Rectum, anus and anal canalFING000001971.15e-03
10241RBPMS2 levelsGCST904704411.15e-03
10242Cardiorespiratory fitness slopeGCST900933191.14e-03
10243Cognitive performanceGCST0065721.14e-03
10244DNA methylation-estimated granulocyte proportionsGCST900142871.14e-03
10245Completion of the aide-memoireGCST900127931.13e-03
10246Juvenile arthritis (FINNGEN)FING000007041.13e-03
10247IDP dMRI ProbtrackX L2 ilf lGCST900042871.13e-03
10248CCL13/CCL2 ratioGCST903136751.13e-03
10249Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T207ECGA0002071.13e-03
10250ENO2/ITGB1BP2 ratioGCST903146611.13e-03
10251Sedentary behavior at workGCST901043451.12e-03
10252Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T127ECGA0001271.12e-03
10253Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T265ECGU0002651.12e-03
10254Time spent driving | Physical activityUKBB000008181.11e-03
10255HLA-A levelsGCST904694571.11e-03
10256Prescriptions - thyroid hormone | hormoneUKBB000007051.11e-03
10257Prescriptions - levothyroxine | thyroid hormoneUKBB000006871.11e-03
10258VEGFA levelsGCST900119951.11e-03
10259PLEKHO1 levelsGCST904702561.11e-03
10260Urine adenosine levels in chronic kidney diseaseGCST902647571.11e-03
10261NPHS1 levelsGCST904700701.10e-03
10262DTI TBSS L1 External capsule LGCST903844611.10e-03
10263Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T74ECGA0000741.10e-03
10264ARHGEF12 levelsGCST904683581.10e-03
10265CCL17/GRK5 ratioGCST903136871.09e-03
10266Left-hemisphere visual network to right-hemisphere visual network white-matter structural connectivityGCST903026551.09e-03
10267Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST906687351.09e-03
10268Spondylosis without myelopathy (PheCode 721.1)GCST904762361.08e-03
10269Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T444ECGA0004441.08e-03
10270CST6/NECTIN4 ratioGCST903143031.08e-03
10271aseg rh intensity Cerebellum-CortexGCST900037811.08e-03
10272X-08402 levelsGCST902435381.08e-03
10273Elevated prostate specific antigen [PSA] (PheCode 796)GCST904762771.08e-03
10274Left-hemisphere visual network to caudate white-matter structural connectivityGCST903026631.08e-03
10275Suicide or other Intentional self-harmFING000013451.08e-03
10276IDP dMRI ProbtrackX MD ilf lGCST900042331.07e-03
10277Breast sizeGCST0066551.07e-03
10278Lichen sclerosus et atrophicusFING000007231.07e-03
10279Idiopathic pulmonary fibrosisFING000006591.07e-03
10280BIN2/FYB1 ratioGCST903135051.07e-03
10281red blood cell count (RBC, maximum, inv-norm transformed)GCST904763431.07e-03
10282Panic attacks | Mental distressUKBB000006341.07e-03
10283Glaucoma | GlaucomaUKBB000002861.07e-03
10284Feeling guiltyGCST0069451.06e-03
10285Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T451ECGA0004511.06e-03
10286Calcific tendinitis of shoulderFING000002351.06e-03
10287TAB2 levelsGCST904707961.06e-03
10288Medication use (calcium channel blockers)GCST900187671.06e-03
10289Bone density T-scoreGCST902786201.06e-03
10290Triglyceride to HDL cholesterol ratioGCST902959531.05e-03
10291ENO2/TXNDC5 ratioGCST903146711.05e-03
10292Glaucoma | sense organsUKBB000002871.05e-03
10293MAP2 levelsGCST904698531.05e-03
10294Disorders of sclera, cornea, iris and ciliary bodyFING000004581.05e-03
10295Operation code - squint correction | OperationsUKBB000005661.04e-03
10296HNRNPK/VASH1 ratioGCST903150711.04e-03
10297ADAMTS15/SULT2A1 ratioGCST903131711.04e-03
10298Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T477ECGA0004771.04e-03
10299Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T264ECGU0002641.04e-03
10300CLEC4D/TGFA ratioGCST903141171.03e-03
10301LAIR2 levelsGCST904697291.03e-03
10302Osteochondrodysplasia with defects of growth of tubular bones and spineFING000009101.03e-03
10303Percentage of M9 (GP18)GCST906684621.03e-03
10304Rheumatoid arthritisGCST901322241.03e-03
10305Atrial fibrillation and flutterFING000001261.03e-03
10306Right-hemisphere dorsal attention network to hippocampus white-matter structural connectivityGCST903028101.03e-03
10307SCLY levelsGCST904705461.02e-03
10308Benign neoplasm of colon, rectum, anus and anal canalFING000001551.02e-03
10309Alkylphosphatidylcholine (O-16:0/16:0) levelsGCST900249131.02e-03
10310aparc-pial lh area pericalcarineGCST900031611.02e-03
10311DTI TBSS L1 FornixGCST903844331.02e-03
10312wg lh intensity-contrast inferiortemporalGCST900038001.02e-03
10313CCL20 levelsGCST900120771.02e-03
10314CCL4 levelsGCST902747701.02e-03
10315Weight, inverse-rank normalizedFING000014471.02e-03
10316T1 FreeSurfer a2009s rh S temporal sup volumeGCST903851101.02e-03
10317DTI TBSS L3 Posterior thalamic radiation LGCST903845531.02e-03
10318T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855341.01e-03
10319CES2 levelsGCST904687191.01e-03
10320Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423ECGU0004231.01e-03
10321ART3/GPC1 ratioGCST903133611.01e-03
10322Tachycardia NOS (PheCode 427.7)GCST904759791.01e-03
10323Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6ECGU0000061.00e-03
10324Nontoxic multinodular goitreFING000008881.00e-03
10325Eosinophill percentage (UKB data field 30210)GCST904680691.00e-03
10326Cereal consumption (bowls per week) (UKB data field 1458)GCST901329829.99e-04
10327FCER2/TREML2 ratioGCST903147929.99e-04
10328ADAMTS15/CLMP ratioGCST903131709.97e-04
10329IDP dMRI ProbtrackX ISOVF ilf rGCST900045409.95e-04
10330Temporomandibular joint disordersFING000013549.93e-04
10331X-16087 levelsGCST902005379.92e-04
10332Glaucoma (primary open-angle)GCST903997259.90e-04
10333GIPC2 levelsGCST904693479.89e-04
10334NT5C3A/SCRN1 ratioGCST903155699.89e-04
10335Waist-hip indexGCST0122289.89e-04
10336rfMRI amplitudes (ICA100 node 12)GCST900046009.87e-04
10337Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T33ECGU0000339.86e-04
10338ACY3 levelsGCST904682139.85e-04
10339Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING000007569.84e-04
10340Orotidine levelsGCST902006819.83e-04
10341Main speciality of consultant (recoded) - Anaesthetics | Summary AdministrationUKBB000004139.82e-04
10342Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T208ECGA0002089.81e-04
10343Acute pancreatitisFING000000279.80e-04
10344Chronic sputum productionGCST902699029.79e-04
10345Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142ECGU0001429.78e-04
10346Atrial flutter (PheCode 427.22)GCST904759739.76e-04
10347Diastolic blood pressure, automated reading | Blood pressureUKBB000001739.69e-04
10348Irregular mensesFING000007019.69e-04
10349Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000001769.69e-04
10350Succinoyltaurine levelsGCST902002359.67e-04
10351OSM/TGFA ratioGCST903155909.65e-04
10352ICD10 C50.9: Malignant neoplasm of breast of unspecified siteGCST900438899.62e-04
10353Mineral and other dietary supplements - None of the above | MedicationUKBB000004749.55e-04
10354EPHB6 levelsGCST904691339.53e-04
10355Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T268ECGU0002689.49e-04
10356aparc-Desikan rh volume parsopercularisGCST900028189.49e-04
10357DTI autoptx L3 atr l tractGCST903851959.48e-04
10358aparc-a2009s lh area G+S-subcentralGCST900033009.47e-04
10359Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T480ECGU0004809.44e-04
10360Addison's diseaseGCST900118719.43e-04
10361CCN2/EDAR ratioGCST903137119.43e-04
10362IDP dMRI TBSS MD Superior fronto-occipital fasciculus RGCST900040699.41e-04
10363Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T26ECGU0000269.40e-04
10364Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)FING000007709.40e-04
10365Volume of left medial nucleusGCST904748929.36e-04
10366HydrocephalusFING000006289.35e-04
10367Left-hemisphere default mode network to caudate white-matter structural connectivityGCST903027689.35e-04
10368DTI autoptx L1 fmi tractGCST903851509.35e-04
10369Fruit juice likingGCST900947689.35e-04
10370FCRL1 levelsGCST904692059.35e-04
10371Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000001779.34e-04
10372Cancer (UKB data field 2453)GCST900436289.33e-04
10373Seropositive rheumatoid arthritis, wideFING000012989.33e-04
10374GHRL levelsGCST904693419.33e-04
10375Seborrhoeic dermatitisFING000012829.32e-04
10376AHSG levelsGCST904682639.31e-04
10377UXS1 levelsGCST904710239.30e-04
10378Knee extension strengthGCST903195029.29e-04
10379TCL1A/TNFRSF13C ratioGCST903159129.27e-04
10380Alcohol drinker status: current vs never (UKB data field 20117)GCST901329249.26e-04
10381Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T52ECGU0000529.23e-04
10382IDP dMRI ProbtrackX ISOVF ilf lGCST900045399.20e-04
10383IDP T1 FAST ROIs R intracalc cortexGCST900024989.20e-04
10384Takes medication for Macular Degeneration?GCST904753879.18e-04
10385T1 CAT volume L VIIIaGCST903841279.16e-04
10386CALCOCO1/TJAP1 ratioGCST903136119.14e-04
10387Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T437ECGA0004379.13e-04
10388Peak expiratory flowGCST0074309.12e-04
10389Illnesses of mother - None of the above (group 1) | Family historyUKBB000003499.09e-04
10390MB levelsGCST904698699.08e-04
103911-palmitoylglycerophosphoethanolamine levelsGCST902438359.05e-04
10392CXCL10 levelsGCST902747809.04e-04
10393NH4_C22:4 Cholesteryl ester levels in chronic kidney diseaseGCST902572279.03e-04
10394Sleep apnea with BMI < 30GCST906247978.97e-04
10395Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T459ECGA0004598.97e-04
10396Methods of admission to hospital (recoded) - Elective admission: Planned | Summary AdministrationUKBB000004628.95e-04
10397SCPEP1 levelsGCST904705538.91e-04
10398Atopic dermatitisGCST900185648.91e-04
10399AGRP levelsGCST900120638.89e-04
10400Left-hemisphere default mode network to right-hemisphere limbic network white-matter structural connectivityGCST903027648.87e-04
10401Left ventricular outflow tract obstruction, narrow definitionFING000007188.86e-04
10402Pregnancy with abortive outcomeFING000012058.86e-04
10403Hemoglobin A1c levelsGCST902786328.85e-04
10404Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T464ECGA0004648.83e-04
10405EDAR/TXNDC5 ratioGCST903145938.79e-04
10406aparc-Desikan rh area caudalmiddlefrontalGCST900031108.75e-04
10407T1 FreeSurfer DKT lh precentral thicknessGCST903842468.75e-04
10408Thyrotoxicosis with diffuse goitreFING000013618.68e-04
10409HLAE/IL15 ratioGCST903150618.68e-04
10410SCGB1A1 levelsGCST904705408.67e-04
10411Retinal vascular disordersFING000012628.67e-04
10412Other and unspecified psoriasisFING000009508.66e-04
10413Testicular hypofunction (PheCode 257.1)GCST904756978.66e-04
10414IDP dMRI TBSS L2 Posterior thalamic radiation LGCST900041528.66e-04
10415Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T13ECGU0000138.64e-04
10416aparc-a2009s lh area G-precuneusGCST900033268.60e-04
10417Right-hemisphere visual network to amygdala white-matter structural connectivityGCST903027868.51e-04
10418DSCAM levelsGCST904690418.47e-04
10419Diastolic blood pressureGCST903016988.44e-04
10420Crohn's diseaseGCST0041328.41e-04
10421VEGFD levelsGCST900120698.38e-04
10422NRAC levelsGCST906179918.37e-04
10423Myasthenia gravisGCST904321568.36e-04
10424BA-exvivo lh area BA6GCST900032138.35e-04
10425Snoring | SleepUKBB000007848.31e-04
10426Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T440ECGA0004408.25e-04
10427Zoster infectionGCST900187218.24e-04
10428Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T40ECGU0000408.21e-04
10429GZMH levelsGCST904694258.18e-04
10430IDO1 levelsGCST904695068.18e-04
10431Plasma X-24947 levels in chronic kidney diseaseGCST902668168.18e-04
10432Phosphatidylcholine_38:5_[M+H]1+/Phosphatidylethanolamine_41:5_[M+H]1+/Phosphatidate_43:6_[M+NH4]1+ levelsGCST900603958.16e-04
10433PRR15 levelsGCST904247908.15e-04
10434Insomnia complaintsGCST0064888.14e-04
10435wg lh intensity-contrast lateraloccipitalGCST900038028.13e-04
10436FCRL5/MZB1 ratioGCST903148048.11e-04
10437Skin and soft tissue infectionsGCST900134118.09e-04
10438CHGA levelsGCST904687418.06e-04
10439ITGB1BP2 levelsGCST900120588.06e-04
10440DAB2/LYN ratioGCST903143658.05e-04
10441DEFA1 or DEFA1B levelsGCST904689798.02e-04
10442Total Ceramide levelsGCST900245788.01e-04
10443Nontoxic nodular goiter (PheCode 241)GCST904756388.00e-04
10444Open-angle glaucoma (PheCode 365.1)GCST904758727.99e-04
10445Operative procedures - Injection of therapeutic substance into joint | Summary OperationsUKBB000005827.98e-04
10446DSG3/FABP9 ratioGCST903145597.97e-04
10447IDP dMRI TBSS L1 External capsule LGCST900041087.94e-04
10448CLMP/PIK3IP1 ratioGCST903141347.93e-04
10449CST5 levelsGCST904688957.91e-04
10450RETN/RNASET2 ratioGCST903157687.90e-04
10451Prostate cancerGCST902747147.90e-04
10452ABL1/CC2D1A ratioGCST903131487.89e-04
10453Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T276ECGA0002767.88e-04
10454Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T436ECGU0004367.88e-04
10455IL12A or IL12B levelsGCST904695487.88e-04
10456Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T52ECGA0000527.87e-04
10457Salami likingGCST900948257.83e-04
10458FCRLB levelsGCST904692107.82e-04
10459Plasma methylsuccinoylcarnitine levels in chronic kidney diseaseGCST902655087.82e-04
10460ARHGAP25 levelsGCST904683537.77e-04
10461Hernia abdominopelvic cavityGCST900860877.74e-04
104621-margaroyl-2-linoleoyl-GPC (17:0/18:2) metabolite levelGCST906160137.73e-04
10463Coffee type - Instant coffee | DietUKBB000001417.70e-04
10464KLK8/WFDC12 ratioGCST903152597.69e-04
10465CX3CL1 levelsGCST902412047.69e-04
10466aparc-a2009s rh thickness G-cuneusGCST900036877.68e-04
10467All influenzaFING000000647.66e-04
10468CD20 on IgD- CD24- B cellGCST900017537.66e-04
10469CD300E/CD59 ratioGCST903137947.65e-04
10470TCN2 levelsGCST904708207.64e-04
10471CD63/EDAR ratioGCST903138647.64e-04
10472DOK2/GRAP2 ratioGCST903145317.61e-04
10473IDP T1 SIENAX white normalised volumeGCST900024327.49e-04
10474DTI TBSS FA External capsule RGCST903844127.48e-04
10475T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST903209017.47e-04
10476IDP T1 FAST ROIs R thalamusGCST900025487.46e-04
10477PTPN1 levelsGCST904703767.45e-04
10478Myocardial fractal dimension (slice 3)GCST900002897.41e-04
10479CCL7 levelsGCST904685857.41e-04
10480EGLN1 levelsGCST904690877.39e-04
10481Left-hemisphere visual network to left-hemisphere visual network white-matter structural connectivityGCST903026487.36e-04
10482red blood cell count (RBC, mean, inv-norm transformed)GCST904763477.33e-04
10483Female infertility, associated with anovulationFING000005377.31e-04
10484IDP dMRI TBSS L3 Splenium of corpus callosumGCST900041757.31e-04
10485CD46/TIMP1 ratioGCST903138377.28e-04
10486T1 CAT volume L CingulateGyrusanteriordivisionGCST903840567.28e-04
10487HyperthyroidismGCST903193197.27e-04
10488PALM2 levelsGCST904701527.25e-04
10489Left-hemisphere control network to pallidum white-matter structural connectivityGCST903027557.25e-04
10490Primary open angle glaucoma (PheCode 365.11)GCST904758757.21e-04
10491aparc-a2009s rh volume G-precentralGCST900030277.15e-04
10492Been in a confiding relationship as an adult | Traumatic eventsUKBB000000887.14e-04
10493Allergic contact dermatitisFING000000687.13e-04
10494Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T433ECGA0004337.13e-04
10495Early age-related macular degenerationGCST0107237.12e-04
10496T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 4)GCST903208237.12e-04
10497FADD/PTPN6 ratioGCST903147757.11e-04
10498aparc-pial rh area caudalmiddlefrontalGCST900031777.10e-04
10499Kynurenine levelsGCST902434777.10e-04
10500Weight (minimum, inv-normal transformed)GCST904764667.06e-04
10501IL2RA/NCR1 ratioGCST903151617.04e-04
10502Qualifications - O levels/GCSEs or equivalent | EducationUKBB000007317.04e-04
10503Scar conditions and fibrosis of skin (PheCode 701.2)GCST904761987.04e-04
10504Medication use (antihypertensives)GCST900187647.03e-04
10505Attention deficit hyperactivity disorder (adjusted for age, sex)GCST902751477.02e-04
10506Skin sebum (glabella)GCST905027977.02e-04
10507Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | DietUKBB000005016.99e-04
10508Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T438ECGA0004386.99e-04
10509Diverticulitis (PheCode 562.2)GCST904760776.96e-04
10510SLAMF7/TXNDC15 ratioGCST903158506.95e-04
10511Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T19ECGU0000196.92e-04
10512SNAP29/SPARC ratioGCST903158606.91e-04
10513Operation code - tonsillectomy +/- adenoids | OperationsUKBB000005676.91e-04
10514KLK11/KLK8 ratioGCST903152546.89e-04
10515IBD (strict) with PSCFING000006576.87e-04
10516PSPN levelsGCST904703646.85e-04
10517CD69/CEP43 ratioGCST903138676.84e-04
10518IDP dMRI TBSS MO Middle cerebellar peduncleGCST900039526.84e-04
10519Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T446ECGA0004466.84e-04
10520DTI autoptx MD atr l tractGCST903852226.83e-04
10521Plasma methylsuccinate levels in chronic kidney diseaseGCST902655066.83e-04
10522HS6ST2 levelsGCST904694806.81e-04
10523EDN1 levelsGCST904690736.80e-04
10524Operative procedures - Direct current cardioversion | Summary OperationsUKBB000005766.79e-04
10525CD160 levelsGCST904685996.78e-04
10526Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T219ECGU0002196.78e-04
10527Turnip likingGCST900948616.77e-04
10528Chronic obstructive pulmonary disease in non-current smokersGCST900165946.74e-04
10529Malignant melanoma, excluding all cancers (controls excluding all cancers)FING000007506.73e-04
10530Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T51ECGU0000516.73e-04
10531Principal component-derived dietary pattern 21GCST901330266.72e-04
10532CCN3 levelsGCST902424926.70e-04
10533IGLC2 levelsGCST904695366.70e-04
10534THY1 levelsGCST904708616.68e-04
10535Volume of right paralaminar nucleusGCST904750516.67e-04
10536LGALS1 levelsGCST904697596.67e-04
10537diastolic blood pressure (DBP, maximum, inv-normal transformed)GCST904752526.66e-04
10538Left-hemisphere visual network to accumbens white-matter structural connectivityGCST903026686.66e-04
10539Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T231ECGA0002316.66e-04
10540IDP dMRI TBSS L1 Sagittal stratum RGCST900041056.63e-04
10541aparc-pial rh area inferiorparietalGCST900031816.62e-04
10542Acute alcohol intoxication, ICD10FING000000156.60e-04
10543ICAM3/SLAMF7 ratioGCST903151236.59e-04
10544eosinophil (fraction, maximum, inv-norm transformed)GCST904752976.58e-04
10545ERBIN/SNAP29 ratioGCST903146976.58e-04
10546GPKOW levelsGCST904693926.57e-04
10547FLT3LG levelsGCST902747916.56e-04
10548HippSubfield lh volume CA3-bodyGCST900026806.51e-04
10549Cancer of urinary organs (incl. kidney and bladder) (PheCode 189)GCST904755936.51e-04
10550SnoringGCST0097606.50e-04
10551Diseases of the digestive systemFING000004296.49e-04
10552Insulin fold change during an oral glucose tolerance test (adjusted for BMI)GCST902675676.47e-04
10553Melanomas of skin (PheCode 172.11)GCST904755786.46e-04
10554AmygNuclei rh volume Medial-nucleusGCST900026636.44e-04
10555Facial wrinkles (under eye)GCST900949036.44e-04
10556GUCA2A/LGALS4 ratioGCST903149986.42e-04
10557ANXA3/ANXA4 ratioGCST903132786.42e-04
10558Peritonsillar abscessFING000011606.42e-04
10559Total bile acid levels in pregnancyGCST904541986.41e-04
10560RELT levelsGCST904704536.41e-04
10561Second line medication for Crohn's diseaseFING000012846.40e-04
10562GSTA1/RBP5 ratioGCST903149956.40e-04
10563T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81)GCST903206446.39e-04
10564IDP dMRI ProbtrackX FA ar rGCST900039266.38e-04
10565aparc-DKTatlas lh area pericalcarineGCST900032536.34e-04
10566CD84/GP6 ratioGCST903139146.33e-04
10567TACC3/TBC1D23 ratioGCST903159006.31e-04
10568Myocardial fractal dimension (slice 6)GCST900002926.26e-04
10569TRIM40 levelsGCST904709686.25e-04
10570Eosinophill percentage | Blood countUKBB000002076.19e-04
10571Acute pancreatitisGCST902553756.17e-04
10572Tyrosine levelsGCST902004276.16e-04
10573Right-hemisphere default mode network to hippocampus white-matter structural connectivityGCST903028486.15e-04
10574Left ventricular end systole inferior wall thicknessGCST902785096.13e-04
10575Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9)GCST904759086.12e-04
10576SAP18 levelsGCST902414326.11e-04
10577ErysipelasFING000005186.09e-04
10578FSTL3/SPON2 ratioGCST903148846.08e-04
10579Falls in the last year | General healthUKBB000002356.06e-04
10580Birth asphyxiaFING000002186.05e-04
10581IDP dMRI TBSS MO Anterior corona radiata RGCST900039746.05e-04
10582ATOX1/SNAP29 ratioGCST903133746.03e-04
10583AMBN levelsGCST904682876.00e-04
10584Sleep disorders (PheCode 327)GCST904758236.00e-04
10585Plasma iron levelsGCST901005466.00e-04
10586CXCL5/MESD ratioGCST903143505.99e-04
10587Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T428ECGA0004285.98e-04
10588CCL4 levelsGCST0044335.97e-04
10589SERPINB1/TMSB10 ratioGCST903158305.96e-04
10590FCRL2/LY9 ratioGCST903147995.95e-04
10591ART3/RGMB ratioGCST903133635.95e-04
10592Type 2 diabetesGCST900187065.93e-04
10593LifespanGCST905518865.93e-04
10594T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 5)GCST903205685.90e-04
10595Mean arterial pressureGCST900187435.89e-04
10596KLK8/LY6D ratioGCST903152575.89e-04
10597Prescriptions - prostaglandin analogUKBB000006975.89e-04
10598LMNB1 levelsGCST904697815.89e-04
10599CALCOCO1/IKBKG ratioGCST903136025.88e-04
10600T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78)GCST903206415.88e-04
10601Smoking status (weighted GWA)GCST902673035.86e-04
10602CD40LG/TNFSF14 ratioGCST903138275.86e-04
10603CFHR1 levelsGCST906185035.83e-04
10604Tyrosine levels (UKB data field 23469)GCST902695665.82e-04
10605Use of sun/uv protection | Sun exposureUKBB000008875.81e-04
10606N-formylanthranilic acid levelsGCST901999605.80e-04
10607T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 79)GCST903206425.80e-04
10608Chronic obstructive pulmonary disease x current smoker interaction (main effect)GCST900165915.79e-04
10609C4BPB/ENTPD5 ratioGCST903135565.78e-04
10610Systolic blood pressureGCST904727805.78e-04
10611LAT2/MANF ratioGCST903152775.77e-04
10612Octadecanedioylcarnitine (C18-DC) levelsGCST901999925.75e-04
10613GanglionFING000005635.72e-04
10614CCL4 levelsGCST900120525.70e-04
10615Hypoplasia of dental enamel, including avohilmoFING000006525.70e-04
10616IDP dMRI TBSS L1 Superior fronto-occipital fasciculus RGCST900041175.70e-04
10617CD19 on IgD- CD38- B cellGCST900017335.70e-04
10618GlaucomaGCST904681295.66e-04
10619ICD10 O12: Gestational oedema and proteinuria without hypertensionGCST904542315.66e-04
10620IDP T1 FAST ROIs R planum temporaleGCST900025425.62e-04
10621Lysoalkylphosphatidylcholine (O-22:0) levelsGCST900241955.61e-04
10622BCL2 levelsGCST904684335.60e-04
10623SSC4D levelsGCST904707475.59e-04
10624Mandibular retrognathiaFING000007845.58e-04
10625Principal component-derived dietary pattern 20GCST901330255.57e-04
10626IFNLR1 levelsGCST904695185.56e-04
10627Cerebrospinal fluid methylmalonate (MMA) levelsGCST903182435.55e-04
10628Treatment or medication use - ezetimibe (UKB data field 20003_1141192736)GCST900425415.54e-04
10629KRT8 levelsGCST904697205.52e-04
10630KITLG levelsGCST904284325.51e-04
10631Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98ECGA0000985.48e-04
10632Hypertension, essentialFING000006385.46e-04
10633Other specified cardiac dysrhythmias (PheCode 427.3)GCST904759755.44e-04
10634DFFA/FOXO1 ratioGCST903144565.43e-04
10635ThalamNuclei rh volume MGNGCST900027375.43e-04
10636CEP85/ZBTB16 ratioGCST903140265.43e-04
10637TNFRSF17 levelsGCST904709085.39e-04
10638T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47)GCST903206105.36e-04
10639CX3CL1/EPHB6 ratioGCST903143245.33e-04
10640ThalamNuclei lh volume PuAGCST900027205.32e-04
10641OMG levelsGCST904701245.32e-04
10642MST1 levelsGCST904699525.30e-04
10643CD69/CDKN2D ratioGCST903138665.30e-04
10644Right-hemisphere somatomotor network to right-hemisphere default mode network white-matter structural connectivityGCST903027935.29e-04
10645aparc-a2009s lh volume G-pariet-inf-SupramarGCST900029505.29e-04
10646Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T73ECGA0000735.26e-04
10647Plasma 2-aminobutyrate levels in chronic kidney diseaseGCST902643395.26e-04
10648AmygNuclei rh volume Central-nucleusGCST900026625.23e-04
10649Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T14ECGU0000145.23e-04
10650FOXO3 levelsGCST904692665.19e-04
10651T1 FreeSurfer aseg Brain-StemGCST903841495.17e-04
10652Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T432ECGA0004325.16e-04
10653Illnesses of siblings - None of the above (group 1) | Family historyUKBB000003535.16e-04
10654Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)FING000008645.15e-04
10655Cardiometabolic multimorbidityGCST902747235.15e-04
10656FAM3B levelsGCST904691865.14e-04
10657LYN/TACC3 ratioGCST903153505.14e-04
10658Smoked fish likingGCST900948415.14e-04
10659Treatment or medication use - amlodipine (UKB data field 20003_1140879802)GCST900421955.13e-04
10660Diverticular disease of intestineFING000004715.13e-04
10661FCAR/LY96 ratioGCST903147885.11e-04
10662Sphingomyelin (d18:1/20:0, d16:1/22:0) levelsGCST902000015.09e-04
10663FYN levelsGCST902432005.09e-04
10664IDP dMRI TBSS L1 Posterior corona radiata LGCST900041025.06e-04
10665Systolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000008075.04e-04
10666Systolic blood pressure, automated reading | Blood pressureUKBB000008035.02e-04
10667SIRPB1 levelsGCST904706405.02e-04
10668CHCHD6 levelsGCST904687395.02e-04
10669S100A11/SERPINB8 ratioGCST903157995.00e-04
10670CA1/CA3 ratioGCST903135724.98e-04
10671EmphysemaFING000004964.96e-04
10672Celiac disease (PheCode 557.1)GCST900441584.95e-04
10673Pulmonary fibrosisGCST900186884.95e-04
10674EBAG9/TBCB ratioGCST903145674.94e-04
10675Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T455ECGA0004554.91e-04
10676Prostate cancerGCST904281174.89e-04
10677TNFRSF19 levelsGCST904709094.88e-04
10678Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T435ECGU0004354.88e-04
10679N-palmitoyl-heptadecasphingosine (d17:1/16:0) levelsGCST902001154.88e-04
10680SPINT1 levelsGCST902417174.87e-04
10681Excessive vomiting in pregnancyFING000005234.87e-04
10682Suggestive for eosinophilic asthmaFING000013444.87e-04
10683Polyglandular dysfunctionFING000011864.86e-04
10684GlaucomaGCST900186324.83e-04
10685Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T16ECGU0000164.83e-04
10686Cleft hard palate NOSFING000003064.83e-04
10687MyopiaFING000008534.82e-04
10688Illnesses of father - High blood pressure | Family historyUKBB000003434.81e-04
10689Systolic blood pressure, combined automated + manual reading | Cardiovascular measurementUKBB000008064.81e-04
10690Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T70ECGA0000704.80e-04
10691Total bilirubin levels (UKB data field 30840)GCST904681044.80e-04
10692Plantar fascial fibromatosisFING000011694.79e-04
10693MANF/PTPN6 ratioGCST903153664.79e-04
10694Seminoma of testis, excluding all cancers (controls excluding all cancers)FING000012894.78e-04
10695RCC1 levelsGCST904704434.77e-04
10696Prostate cancerGCST0060854.75e-04
10697IDP T1 FAST ROIs L cuneal cortexGCST900025134.75e-04
10698Physical activity (standard GWA)GCST902672924.74e-04
10699Cancer code, self-reported: prostate cancer (UKB data field 20001_1044)GCST900419054.73e-04
10700T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 30)GCST903208494.72e-04
10701aparc-a2009s rh thickness G-temporal-middleGCST900037144.70e-04
10702Open biteFING000009034.70e-04
10703CataractsGCST904753824.68e-04
10704Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T260ECGA0002604.65e-04
10705PCSK7 levelsGCST904701764.63e-04
10706Right subiculum volume (body)GCST902679804.62e-04
10707Sleep duration | SleepUKBB000007774.59e-04
10708Ratio of bis-allylic bonds to double bonds in lipidsGCST901327444.57e-04
10709Erectile dysfunction [ED] (PheCode 605)GCST904761614.55e-04
10710ADH1B levelsGCST904682434.54e-04
10711CCL17/PDGFB ratioGCST903136884.54e-04
10712RGMB/SMOC2 ratioGCST903157704.53e-04
10713Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)FING000013304.53e-04
10714aseg lh volume Inf-Lat-VentGCST900026174.52e-04
10715Pre-eclampsia or eclampsiaFING000012014.47e-04
10716Biological Sibling: AsthmaGCST904763724.47e-04
10717Allergic asthma (mode)FING000000664.46e-04
10718X-21286 levelsGCST902005624.45e-04
10719CSTB levelsGCST901792724.45e-04
10720Pollen allergyFING000011764.41e-04
10721ANXA3/SERPINB1 ratioGCST903132894.41e-04
10722PLIN1 levelsGCST904702584.40e-04
10723Other disorders of glucose regulation and pancreatic internal secretionFING000010284.39e-04
10724Processed meat consumptionGCST901329954.38e-04
10725Cerebral aneurysm, nonrupturedFING000002634.35e-04
10726IDP dMRI TBSS OD Pontine crossing tractGCST900044034.35e-04
10727Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary OperationsUKBB000005754.34e-04
10728Left ventricle sphericity indexGCST902684024.32e-04
10729T1 FreeSurfer a2009s lh S postcentral areaGCST903847344.32e-04
10730EZR levelsGCST904691624.30e-04
10731Primary biliary cholangitisGCST0031294.29e-04
10732Falling riskGCST900128574.27e-04
10733REST UKBBICA NODEamps25 0003GCST903854864.26e-04
10734EDAR/TNFSF12 ratioGCST903145914.26e-04
10735Chronic ulcer of skin, not elsewhere classifiedFING000003004.25e-04
10736CD8A levelsGCST904686554.25e-04
10737Body mass index (BMI, mean, inv-normal transformed)GCST904751564.25e-04
10738COLEC12/NBL1 ratioGCST903141834.25e-04
10739F-glutamate liking (derived food-liking factor)GCST900947724.24e-04
10740PPP1R12A/SPARC ratioGCST903157124.23e-04
10741PAEP levelsGCST904701444.23e-04
10742Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T20ECGU0000204.22e-04
10743DTI TBSS FA Anterior corona radiata LGCST903844034.21e-04
10744SEPHS1 levelsGCST902427404.19e-04
10745ADIPOQ levelsGCST904682454.19e-04
10746T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 118)GCST903206814.17e-04
10747X-11786--methylcysteine levelsGCST902436544.16e-04
10748Maximum digits remembered correctly | Numeric memoryUKBB000004304.16e-04
10749Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T439ECGA0004394.15e-04
10750Atrial fibrillation and flutter with reimbursementFING000001274.14e-04
10751ARHGAP25/RNF41 ratioGCST903133454.13e-04
10752SLAMF1 levelsGCST902748354.13e-04
10753CLEC1B/PPP1R2 ratioGCST903141014.11e-04
10754Friendships satisfaction | Mental healthUKBB000002734.11e-04
10755Hyperparathyroidism (PheCode 252.1)GCST904756934.10e-04
10756DTI TBSS L1 Cingulum cingulate gyrus LGCST903844634.10e-04
10757Volume of right central nucleusGCST904750274.08e-04
10758Glucose levelsGCST900187354.08e-04
10759Skin color (cheek, ITA value)GCST905027804.07e-04
10760EDAR/F11R ratioGCST903145764.07e-04
10761Asthma (only as main-diagnosis) (more control exclusions)FING000001144.06e-04
10762eosinophil (fraction, mean, inv-norm transformed)GCST904753004.06e-04
10763Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T469ECGA0004694.04e-04
10764CASP3/SNAP23 ratioGCST903136444.01e-04
10765PODXL2 levelsGCST904702793.97e-04
10766IDP dMRI TBSS L3 Retrolenticular part of internal capsule RGCST900041913.96e-04
10767Skin cancerGCST904755753.94e-04
10768Random glucose levelsGCST902715573.93e-04
10769CA13/TYMP ratioGCST903135683.92e-04
10770Guilty feelings | Mental healthUKBB000002913.92e-04
10771HyperthyroidismGCST904681363.92e-04
10772Retinal detachments and breaksFING000012603.92e-04
10773Vitamin and mineral supplements - None of the above | MedicationUKBB000009013.91e-04
10774PDCD1 levelsGCST904701813.91e-04
10775Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T18ECGU0000183.90e-04
10776CD40/GLOD4 ratioGCST903138143.90e-04
10777ATG4A/TPMT ratioGCST903133703.89e-04
10778FUT8 levelsGCST904692813.88e-04
10779Renal tubulo-interstitial diseasesFING000012513.87e-04
10780Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)FING000007553.87e-04
10781Other symptoms of respiratory system (PheCode 512)GCST904760393.82e-04
10782CXCL5/PPIB ratioGCST903143523.80e-04
10783CXCL5/EDAR ratioGCST903143493.79e-04
10784DPP7 levelsGCST904690353.79e-04
10785DTI autoptx FA ifo r tractGCST903851253.77e-04
10786Inflammatory bowel disease, strict (require KELA)FING000006753.77e-04
10787CD74/JAM2 ratioGCST903138933.77e-04
10788Acute sinusitisFING000000313.77e-04
10789aparc-DKTatlas rh volume parsopercularisGCST900029093.75e-04
10790PPY levelsGCST904703093.74e-04
10791Gamma-CEHC glucuronide levelsGCST901999413.73e-04
10792Macular puckerFING000007453.73e-04
10793LCN2/PRTN3 ratioGCST903153073.72e-04
10794ENO2/HCLS1 ratioGCST903146603.72e-04
10795Other demyelinating diseases of the central nervous systemFING000009953.72e-04
10796FCER2/TNFRSF9 ratioGCST903147913.72e-04
10797Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000001783.71e-04
10798aparc-a2009s lh volume G-oc-temp-med-LingualGCST900029463.70e-04
10799T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54)GCST903206173.70e-04
10800IDP T1 FAST ROIs L parahipp gyrus postGCST900025193.69e-04
10801Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)FING000007773.68e-04
10802aparc-Desikan rh area parstriangularisGCST900031263.68e-04
10803aparc-Desikan rh volume precentralGCST900028243.67e-04
10804Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classifiedFING000004313.67e-04
10805CCL2 levelsGCST900120073.67e-04
10806CancerGCST900860523.65e-04
10807CYTL1 levelsGCST904689403.65e-04
10808Phospholipid levels in very small VLDLGCST901326593.64e-04
10809CCN2/TACC3 ratioGCST903137173.64e-04
10810Abnormal findings examination of lungs (PheCode 514)GCST904760433.64e-04
10811LGALS4/TIE1 ratioGCST903153163.61e-04
10812Left-hemisphere somatomotor network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903026773.59e-04
10813HDAC8 levelsGCST904694383.58e-04
10814Prevotella sp000434975 abundance in stoolGCST900325183.57e-04
10815IDP dMRI TBSS MD Posterior thalamic radiation LGCST900040563.56e-04
10816CLIC5 levelsGCST904217403.56e-04
10817LGALS3 levelsGCST900120093.55e-04
10818ECHDC3 levelsGCST904690623.55e-04
10819Frequency of stair climbing in last 4 weeks | Physical activityUKBB000002663.54e-04
10820Other disorders of synovium, tendon, and bursa (PheCode 727)GCST904762413.53e-04
10821Hemoglobin A1c levelsGCST900187383.53e-04
10822Breast cancerGCST904298463.52e-04
10823TNFRSF1B levelsGCST900120263.52e-04
10824Flat foot [pes planus] (acquired)FING000005453.51e-04
10825PIKFYVE levelsGCST904702353.50e-04
10826Epstein-Barr virus EA-D antibody levelsGCST900068983.50e-04
10827Hip width to body height ratioGCST902702603.50e-04
10828Diastolic blood pressureGCST902786253.49e-04
10829rfMRI connectivity ICA-features 4GCST900063423.46e-04
10830Lymphangioleiomyomatosis (sporadic)GCST0083113.46e-04
10831JCHAIN levelsGCST904696613.46e-04
10832VEGFD levelsGCST904710373.46e-04
10833Sphingomyelin (d18:1/14:0) levels/Sphingomyelin (d16:1/16:0) levelsGCST900245043.46e-04
10834HypertensionFING000006373.45e-04
10835ICA1/MVK ratioGCST903151083.43e-04
10836T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 2)GCST903208213.43e-04
10837aparc-Desikan lh area pericalcarineGCST900030933.42e-04
10838IL5RA/TNFRSF13B ratioGCST903151643.42e-04
10839Sphingomyelin (d16:1/23:0) levels/Sphingomyelin (d17:1/22:0) levelsGCST900257353.41e-04
10840CD27/NBL1 ratioGCST903137743.39e-04
10841MZB1/TNFRSF13B ratioGCST903155093.39e-04
10842CA1 levelsGCST904685103.38e-04
10843ALCAM/SPINT1 ratioGCST903132423.37e-04
10844GP6/TMSB10 ratioGCST903149753.37e-04
10845Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141ECGU0001413.37e-04
10846OsteoporosisFING000009143.33e-04
10847EGLN1/FOXO1 ratioGCST903146163.32e-04
10848Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T31ECGU0000313.32e-04
10849GPLD1 levelsGCST900868903.32e-04
10850CXCL5/SPARC ratioGCST903143553.31e-04
10851Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329333.31e-04
10852aparc-a2009s rh thickness Pole-temporalGCST900037193.30e-04
10853Disorders of bilirubin excretion (PheCode 277.4)GCST904757563.29e-04
10854CXCL9 levelsGCST904689353.28e-04
10855Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T434ECGA0004343.28e-04
10856TGOLN2 levelsGCST904708503.28e-04
10857Corneal opacity and other disorders of cornea (PheCode 364)GCST904758613.24e-04
10858Alkylphosphatidylcholine (O-34:1) levelsGCST900249253.23e-04
10859Number of sexual partners in opposite-sex sexual behaviorGCST900264813.21e-04
10860Added salt consumptionGCST901330013.20e-04
10861Volume of right basal nucleusGCST904750153.19e-04
10862Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB000005093.18e-04
10863SCGB3A1 levelsGCST904705423.18e-04
10864eGFR in diabetes mellitus (strict) case-control group (minimal adjustment)GCST906247813.17e-04
10865Neutrophil percentage of white cells varianceGCST905657013.17e-04
10866CBLIF levelsGCST904685523.17e-04
10867Dermatitis and eczemaFING000004023.17e-04
10868NPHS2 levelsGCST904700713.15e-04
10869TIMP4 levelsGCST904708723.15e-04
10870Phosphatidylcholine_35:2_[M+H]1+/Phosphatidylethanolamine_38:2_[M+H]1+/Phosphatidate_40:3_[M+NH4]1+ levelsGCST900603253.15e-04
10871Ulcerative colitisGCST900187133.14e-04
10872TG levelsGCST904708513.14e-04
10873ISEI occupational scoreGCST904461603.13e-04
10874BCR/FOXO1 ratioGCST903134903.13e-04
10875Eosinophil countGCST900022983.12e-04
10876Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T128ECGA0001283.11e-04
10877Autoimmune diseasesFING000001313.11e-04
10878SnoringGCST0097613.11e-04
10879AmygNuclei rh volume Lateral-nucleusGCST900026583.11e-04
10880IDP dMRI TBSS FA Retrolenticular part of internal capsule RGCST900038973.09e-04
10881Systolic blood pressureGCST900259683.09e-04
10882IDP T1 SIENAX white unnormalised volumeGCST900024333.08e-04
10883Systolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000008093.07e-04
10884FSTL3 levelsGCST904257653.07e-04
10885NUDT5/SERPINB1 ratioGCST903155813.05e-04
10886Left-hemisphere visual network to left-hemisphere salience/ventral attention network white-matter structural connectivityGCST903026513.05e-04
10887Diastolic blood pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB000001793.03e-04
10888Osteoporosis, osteopenia and pathological fracture | musculoskeletalUKBB000006003.03e-04
10889Testicular dysfunction (PheCode 257)GCST904756963.02e-04
10890CD5 levelsGCST904686413.02e-04
10891CAPN3 levelsGCST904685383.02e-04
10892IDP dMRI TBSS L1 Anterior limb of internal capsule LGCST900040923.01e-04
10893PLXDC1 levelsGCST904702633.01e-04
10894TPM2 levelsGCST902431223.01e-04
10895X-13435 levelsGCST902438113.01e-04
10896T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 95)GCST903206582.98e-04
10897Systolic blood pressureGCST904727822.98e-04
10898aparc-pial rh area precuneusGCST900031982.97e-04
10899Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72ECGA0000722.97e-04
10900T1 CAT volume R SupramarginalGyrusanteriordivisionGCST903840372.97e-04
10901PER3 levelsGCST904702102.96e-04
10902Bullous keratopathyFING000002312.94e-04
10903Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T135ECGU0001352.93e-04
10904Coeliac diseaseGCST904681202.93e-04
10905aparc-DKTatlas lh area entorhinalGCST900032382.92e-04
10906PPME1/PSMD9 ratioGCST903157052.92e-04
10907GAST levelsGCST904693072.92e-04
10908HippSubfield rh volume Whole-hippocampal-headGCST900027102.91e-04
10909Crohn's diseaseGCST904753182.88e-04
10910Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000001742.86e-04
10911TFF2 levelsGCST904708362.86e-04
10912Physical activity (Total log acceleration 8am-10am)GCST900614132.86e-04
10913Retinal thickness (functional principal component 6)GCST904557262.85e-04
10914Nasal polyps (PheCode 471)GCST904760192.85e-04
10915Inpatient record format - UK HES Inpatients (2017 format) | Summary AdministrationUKBB000003652.85e-04
10916Age at onset of walkingGCST906510782.84e-04
10917AmygNuclei lh volume Medial-nucleusGCST900026532.83e-04
10918FBP1 levelsGCST904691952.82e-04
10919Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T429ECGA0004292.82e-04
10920BCAM/LGALS4 ratioGCST903134732.81e-04
10921BTN2A1/CSF1 ratioGCST903135412.81e-04
10922Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T440ECGU0004402.80e-04
10923Never eat sugar vs no sugar restrictions (UKB data field 6144)GCST901329342.80e-04
10924Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T448ECGA0004482.80e-04
10925DTI TBSS FA Posterior thalamic radiation LGCST903844092.79e-04
10926SSC-A on plasmacytoid Dendritic CellGCST900020722.78e-04
10927BMPER levelsGCST904684552.78e-04
10928MMP7 levelsGCST904699212.76e-04
10929Chronic obstructive pulmonary disease x ever smoker interaction (main effect)GCST900165862.75e-04
10930KLRD1 levelsGCST904697112.75e-04
10931N-acetyltaurine levelsGCST901999672.74e-04
10932Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T285ECGU0002852.74e-04
10933Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71ECGA0000712.74e-04
10934Medication use (diuretics)GCST900187652.73e-04
10935FOLH1 levelsGCST904692582.72e-04
10936Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T100ECGA0001002.72e-04
10937Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T15ECGU0000152.71e-04
10938Takes medication for migraine headaches?GCST904755472.70e-04
10939OGFR levelsGCST904701182.70e-04
10940Number of sexual partners in opposite-sex sexual behaviorGCST900264822.69e-04
10941BA-exvivo lh thickness V2GCST900035232.69e-04
10942Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T480ECGA0004802.68e-04
10943Eosinophill count (UKB data field 30150)GCST904680682.68e-04
10944BCR levelsGCST904684362.66e-04
10945DBNL/HEXIM1 ratioGCST903144172.66e-04
10946BAX/MAX ratioGCST903134662.65e-04
10947EDAR/F2R ratioGCST903145772.65e-04
10948Asthma-related infectionsFING000001182.65e-04
10949Subclinical hypothyroidism in pregnancyGCST904351972.63e-04
10950Other non-epithelial cancer of skin (PheCode 172.2)GCST904755802.63e-04
10951Actinic keratosis (PheCode 702.1)GCST904762042.62e-04
10952CD27/DLL1 ratioGCST903137712.62e-04
10953Medication use (adrenergics, inhalants)GCST900187792.60e-04
10954Diacylglycerol_36:5_[M+H-H2O]1+ levelsGCST900601872.60e-04
10955Macular degeneration, dry (PheCode 362.21)GCST904758512.59e-04
10956Non-albumin protein levelsUKBB000005032.59e-04
10957Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000006412.59e-04
10958Other non-epithelial cancer of skin | neoplasmsUKBB000006152.59e-04
10959DNAJB14 levelsGCST904690112.58e-04
10960CX3CL1/DSG2 ratioGCST903143232.58e-04
10961CXCL3/CXCL5 ratioGCST903143442.57e-04
10962CD300C/GOLM2 ratioGCST903137882.56e-04
10963GZMA/IL12A_IL12B ratioGCST903150092.56e-04
10964PRKRA levelsGCST904703312.55e-04
10965Comfortable retirement (confirmatory factor analysis Factor 29)GCST903093632.53e-04
10966SPRR3 levelsGCST904707372.53e-04
10967DAPP1/SDC4 ratioGCST903143992.52e-04
10968T1 CAT GM unnormalised volumeGCST903839822.51e-04
10969Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T443ECGA0004432.51e-04
10970Athlete's foot (PheCode 110.12)GCST904755632.50e-04
10971Biological Sibling: Coronary Artery / Coronary Heart DiseaseGCST904763702.50e-04
10972LAT2/SDC4 ratioGCST903152782.48e-04
10973Colon polypGCST900186072.47e-04
10974Horseradish likingGCST900947832.47e-04
10975Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T101ECGA0001012.46e-04
10976MLN levelsGCST904699132.46e-04
10977Restless legs syndromeGCST904353872.46e-04
10978Arthropathies in other diseases classified elsewhereFING000001082.45e-04
10979DTI TBSS MD Body of corpus callosumGCST903845752.45e-04
10980Cancer (standard GWA)GCST902672702.45e-04
10981GZMA/GZMB ratioGCST903150072.43e-04
10982ATOX1/SPARC ratioGCST903133752.43e-04
10983End-diastolic bi-ventricular shape (principal component 5)GCST904484842.43e-04
10984Risk taking (standard GWA)GCST902672982.42e-04
10985IDP T1 FAST ROIs R lingual gyrusGCST900025222.40e-04
10986Left ventricular end systole anterior wall thicknessGCST902785122.38e-04
10987Nontoxic uninodular goiter (PheCode 241.1)GCST904756402.38e-04
10988IDP dMRI TBSS OD External capsule LGCST900044352.37e-04
10989Never eat wheat vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST901329312.36e-04
10990StrokeGCST0069062.36e-04
10991Diastolic blood pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB000001752.35e-04
10992DTI autoptx L1 slf l tractGCST903851602.34e-04
10993Trauma (confirmatory factor analysis Factor 9)GCST903093432.34e-04
10994Lysophosphatidylcholine (24:0) [sn2] levelsGCST900241872.33e-04
10995Rheumatoid arthritis (PheCode 714.1)GCST904762302.33e-04
10996eosinophil (fraction, minimum, inv-norm transformed)GCST904753032.32e-04
10997TNFRSF11B levelsGCST904709032.32e-04
10998Salt added to food | DietUKBB000007622.32e-04
10999Diastolic blood pressureGCST904727772.32e-04
11000Breast cancerGCST0100982.31e-04